A-A-0053001 (DM)
1 June 1987
INTERIM COMMERCIAL ITEM DESCRIPTION
PHENYLPROPANOLAMINE HYDROCHLORIDE AND GUAIFENESIN TABLETS
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient Characteristics:
Shall be a sustained-release tablet containing in each tablet 75 mg Phenylpropanolamine Hydrochloride and 600 mg Guaifenesin.
The sustained-release tablet shall have a duration of action of 8 to 12 hours.
Shall assay to contain the required amounts of Phenylpropanolamine Hydrochloride and Guaifenesin within the applicable assay limits for the tablets when assayed by a suitable, accurate and reproducible method(s).
The sustained-release tablets shall be capable of releasing the Phenylpropanolamine Hydrochloride and Guaifenesin in the quantities and release time as designated in the labeling of the product.
Materials used in the manufacture of the tablets shall be of a pharmaceutical grade.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT). One bottle containing 100 tablets, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business